Drs. Karine Tawagi and Samantha Armstrong Preview ESMO 2024

The Two Onc Docs, Drs. Samantha Armstrong and Karine Tawagi, provide a brief overview of the sessions and data to look out for at the ESMO Congress 2024.

The latter leads the former through the urothelial carcinoma, renal cell carcinoma, and prostate cancer presentations of note, as well as the interviews she plans to host for GU Oncology Now while at the meeting.

Advertisement

Latest News

Advertisement
Advertisement
Editorial Advisory Board

The Uromigos Live and Unplugged 2024

The Uromigos Live & Unplugged 2024

The Uromigos Live & Unplugged 2024 will take place September 27-29 in Nashville, Tennessee.

This meeting is the third annual in-person event hosted by Thomas Powles, MD, and Brian Rini, MD, FASCO, in partnership with Mashup Media, featuring expert panels and audience discussion around the latest data in genitourinary oncology and vision for the future.

Expert Interviews

Knowledge Hubs

Curated clinical content based on conditions, therapies, and technologies

Prostate Cancer
Prostate Cancer

The Uromigos

Podcasts hosted by Professors Thomas Powles, MD, and Brian Rini, MD

Conference Coverage

Live meeting highlights

Brandon TwyfordAdvanced Urothelial Carcinoma | September 12, 2024
Disitamab vedotin plus pembrolizumab shows promising efficacy, manageable safety in HER2+ aUC, with a 61.1% response rate.
Read More
Jordana JampelmCSPC | September 11, 2024
Prognostic and predictive phenotypic biomarkers have been identified for rPFS and OS in de novo mCSPC.
Zachary BessetteMuscle Invasive Urothelial Carcinoma | September 11, 2024
The addition of nivo to trimodality therapy may improve RFS in patients with non-metastatic muscle-invasive bladder cancer.
Jordana JampelAdvanced Renal Cell Carcinoma | September 10, 2024
PFS was improved with nivolumab plus cabozantinib.

Video Insights

Clinical discussions with experts in the field

Network Websites